Suivre
Stefano Caruso
Stefano Caruso
Centre de Recherche des Cordeliers, Université de Paris, Sorbonne Université, INSERM UMRS 1138
Adresse e-mail validée de inserm.fr
Titre
Citée par
Citée par
Année
Molecular classification of hepatocellular adenoma associates with risk factors, bleeding, and malignant transformation
JC Nault, G Couchy, C Balabaud, G Morcrette, S Caruso, JF Blanc, ...
Gastroenterology 152 (4), 880-894. e6, 2017
3562017
Liver cancer initiation requires p53 inhibition by CD44-enhanced growth factor signaling
D Dhar, L Antonucci, H Nakagawa, JY Kim, E Glitzner, S Caruso, ...
Cancer cell 33 (6), 1061-1077. e6, 2018
1792018
Potential role of ANGPTL4 in the cross talk between metabolism and cancer through PPAR signaling pathway
L La Paglia, A Listì, S Caruso, V Amodeo, F Passiglia, V Bazan, D Fanale
PPAR research 2017, 2017
1552017
Analysis of liver cancer cell lines identifies agents with likely efficacy against hepatocellular carcinoma and markers of response
S Caruso, AL Calatayud, J Pilet, T La Bella, S Rekik, S Imbeaud, ...
Gastroenterology 157 (3), 760-776, 2019
1542019
Clinical impact of genomic diversity from early to advanced hepatocellular carcinoma
JC Nault, Y Martin, S Caruso, TZ Hirsch, Q Bayard, J Calderaro, C Charpy, ...
Hepatology 71 (1), 164-182, 2020
1522020
Hepatitis B virus integrations promote local and distant oncogenic driver alterations in hepatocellular carcinoma
C Péneau, S Imbeaud, T La Bella, TZ Hirsch, S Caruso, J Calderaro, ...
Gut 71 (3), 616-626, 2022
1222022
Opposing roles of hepatic stellate cell subpopulations in hepatocarcinogenesis
A Filliol, Y Saito, A Nair, DH Dapito, LX Yu, A Ravichandra, ...
Nature 610 (7931), 356-365, 2022
1082022
High density of tryptase‐positive mast cells in human colorectal cancer: a poor prognostic factor related to protease‐activated receptor 2 expression
A Malfettone, N Silvestris, C Saponaro, G Ranieri, A Russo, S Caruso, ...
Journal of cellular and molecular medicine 17 (8), 1025-1037, 2013
1032013
Adeno-associated virus in the liver: natural history and consequences in tumour development
T La Bella, S Imbeaud, C Peneau, I Mami, S Datta, Q Bayard, S Caruso, ...
Gut 69 (4), 737-747, 2020
982020
Dual targeting of histone methyltransferase G9a and DNA‐methyltransferase 1 for the treatment of experimental hepatocellular carcinoma
M Bárcena‐Varela, S Caruso, S Llerena, G Álvarez‐Sola, I Uriarte, ...
Hepatology 69 (2), 587-603, 2019
962019
Genetics of hepatocellular carcinoma: approaches to explore molecular diversity
S Caruso, DR O’Brien, SP Cleary, LR Roberts, J Zucman‐Rossi
Hepatology 73, 14-26, 2021
832021
Genetic alterations of malignant pleural mesothelioma: association with tumor heterogeneity and overall survival
L Quetel, C Meiller, JB Assié, Y Blum, S Imbeaud, F Montagne, ...
Molecular oncology 14 (6), 1207-1223, 2020
832020
Polyploidy spectrum: a new marker in HCC classification
M Bou-Nader, S Caruso, R Donne, S Celton-Morizur, J Calderaro, ...
Gut 69 (2), 355-364, 2020
822020
microRNA 193a-5p regulates levels of nucleolar-and spindle-associated protein 1 to suppress hepatocarcinogenesis
S Roy, GJ Hooiveld, M Seehawer, S Caruso, F Heinzmann, AT Schneider, ...
Gastroenterology 155 (6), 1951-1966. e26, 2018
822018
Nivolumab, nivolumab–ipilimumab, and VEGFR-tyrosine kinase inhibitors as first-line treatment for metastatic clear-cell renal cell carcinoma (BIONIKK): a biomarker-driven, open …
YA Vano, R Elaidi, M Bennamoun, C Chevreau, D Borchiellini, D Pannier, ...
The Lancet Oncology 23 (5), 612-624, 2022
812022
ESM1 as a marker of macrotrabecular-massive hepatocellular carcinoma
J Calderaro, L Meunier, CT Nguyen, M Boubaya, S Caruso, A Luciani, ...
Clinical Cancer Research 25 (19), 5859-5865, 2019
722019
Telomere length is key to hepatocellular carcinoma diversity and telomerase addiction is an actionable therapeutic target
M Ningarhari, S Caruso, TZ Hirsch, Q Bayard, A Franconi, AL Védie, ...
Journal of Hepatology 74 (5), 1155-1166, 2021
672021
The interplay between metabolism, PPAR signaling pathway, and cancer
D Fanale, V Amodeo, S Caruso
PPAR research 2017, 2017
672017
Impact of microRNAs in resistance to chemotherapy and novel targeted agents in non-small cell lung cancer
C Rolfo, D Fanale, D S Hong, A M Tsimberidou, S A Piha-Paul, P Pauwels, ...
Current pharmaceutical biotechnology 15 (5), 475-485, 2014
572014
BAP1 mutations define a homogeneous subgroup of hepatocellular carcinoma with fibrolamellar-like features and activated PKA
TZ Hirsch, A Negulescu, B Gupta, S Caruso, B Noblet, G Couchy, ...
Journal of Hepatology 72 (5), 924-936, 2020
562020
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20